Skip to menu Skip to content Skip to footer
Professor

Robert Fassett

Email: 

Overview

Availability

Professor Robert Fassett is:
Available for supervision

Works

Search Professor Robert Fassett’s works on UQ eSpace

245 works between 1981 and 2024

101 - 120 of 245 works

2011

Journal Article

Palliative care in end-stage kidney disease

Fassett, Robert, Robertson, Ian K., Mace, Rose, Youl, Loren, Challenor, Sarah and Bull, Rosalind (2011). Palliative care in end-stage kidney disease. Nephrology, 16 (1), 4-12. doi: 10.1111/j.1440-1797.2010.01409.x

Palliative care in end-stage kidney disease

2011

Conference Publication

Ckd.Qld phase 2 survey: Risk factor modification for prevention of progression of chronic kidney disease

Venuthurupalli, S. K., Salisbury, A., Hoy, W. E., Healy, H. and Fassett, R. G. (2011). Ckd.Qld phase 2 survey: Risk factor modification for prevention of progression of chronic kidney disease. 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, 19-21 September 2011. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2011.01490.x

Ckd.Qld phase 2 survey: Risk factor modification for prevention of progression of chronic kidney disease

2011

Journal Article

Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease

Crawford, Amanda, Fassett, Robert G., Coombes, Jeff S., Kunde, Dale A., Ahuja, Kiran D.K., Robertson, Iain K., Ball, Madeleine J. and Geraghty, Dominic P. (2011). Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrology, Dialysis, Transplantation, 26 (9), 2806-2813. doi: 10.1093/ndt/gfq828

Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease

2011

Conference Publication

Atorvastatin Improves Kidney Function in Chronic Kidney Disease Patients Undertaking High Intensity Exercise

Fassett, RG, Robertson, IK, Ball, MJ, Geraghty, DP and Coombes, JS (2011). Atorvastatin Improves Kidney Function in Chronic Kidney Disease Patients Undertaking High Intensity Exercise. ANZSN 2011: 47th Annual Scientific Meeting Australian and New Zealand Society of Nephrology, Adelaide, SA, Australia, 19-21 September 2011. MALDEN: WILEY-BLACKWELL. doi: 10.1111/j.1440-1797.2011.01490.x

Atorvastatin Improves Kidney Function in Chronic Kidney Disease Patients Undertaking High Intensity Exercise

2011

Conference Publication

Views of health professionals about palliative care pathways in patients with chronic kidney disease (ckd)

Fassett, R. G., Robertson, I. K., Mace, R., Youl, L., Challenor, S. and Bull, R. (2011). Views of health professionals about palliative care pathways in patients with chronic kidney disease (ckd). 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, 19-21 September 2011. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2011.01490.x

Views of health professionals about palliative care pathways in patients with chronic kidney disease (ckd)

2011

Conference Publication

Risk Factor Analysis for Renal Function Outcome in Maintenance Renal Transplant Recipients from the ASCERTAIN Study.

Rostaing, L, Fassett, R, Dantal, J, Binet, I, O'Connell, P, Machein, U, Karpov, A, Ulbricht, B and Holdaas, H (2011). Risk Factor Analysis for Renal Function Outcome in Maintenance Renal Transplant Recipients from the ASCERTAIN Study.. American Transplant Congress, Philadelphia Pa, 2011. BLACKWELL MUNKSGAARD.

Risk Factor Analysis for Renal Function Outcome in Maintenance Renal Transplant Recipients from the ASCERTAIN Study.

2011

Conference Publication

Factors associated with the progression of chronic kidney disease in nephrology practices in Australia: A retrospective analysis using management software (audit4)

Boudville, N., Nelson, C., Fassett, R. G., Pedagogos, E., Healy, H., Mangos, G., Moody, H., Kirkland, G., Kay, T., De Crespigny, P. C., Hoffman, D., Kemp, A. and Waugh, D. (2011). Factors associated with the progression of chronic kidney disease in nephrology practices in Australia: A retrospective analysis using management software (audit4). 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, 19-21 September 2011. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2011.01490.x

Factors associated with the progression of chronic kidney disease in nephrology practices in Australia: A retrospective analysis using management software (audit4)

2011

Book Chapter

Bioactive nutritional supplements for chronic kidney disease: potential cost benefits

Gobe, Glenda C., Fassett, Robert G. and Coombes, Jeff S. (2011). Bioactive nutritional supplements for chronic kidney disease: potential cost benefits. Nutrients, dietary supplements, and nutriceuticals: Cost analysis versus clinical benefits. (pp. 301-314) edited by Ronald Ross Watson, Joe K. Gerald and Victor R. Preedy. New York, United States: Springer. doi: 10.1007/978-1-60761-308-4

Bioactive nutritional supplements for chronic kidney disease: potential cost benefits

2011

Journal Article

Biomarkers in chronic kidney disease: A review

Fassett, Robert G., Venuthurupalli, Sree K., Gobe, Glenda C., Coombes, Jeff S., Cooper, Matthew A. and Hoy, Wendy E. (2011). Biomarkers in chronic kidney disease: A review. Kidney International, 80 (8), 806-821. doi: 10.1038/ki.2011.198

Biomarkers in chronic kidney disease: A review

2011

Conference Publication

Patterns of progression in chronic kidney disease (pope) study: Baseline data

Nelson, C., Fassett, R. G., Boudville, N., Pedagogos, E., Healy, H., Mangos, G., Moody, H., Kirkland, G., Kay, T., De Crespigny, P. C., Hoffman, D. and Waugh, D. (2011). Patterns of progression in chronic kidney disease (pope) study: Baseline data. 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, 19-21 September 2011. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2011.01491.x

Patterns of progression in chronic kidney disease (pope) study: Baseline data

2011

Conference Publication

Profile of chronic kidney disease practice in Queensland (ckd.Qld phase 2 survey)

Venuthurupalli, S. K., Salisbury, A., Hoy, W. E., Healy, H. and Fassett, R. G. (2011). Profile of chronic kidney disease practice in Queensland (ckd.Qld phase 2 survey). 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, 19-21 September 2011. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2011.01490.x

Profile of chronic kidney disease practice in Queensland (ckd.Qld phase 2 survey)

2011

Conference Publication

Atorvastatin Slows the Progression of Ckd in Patients with Inflammation

Fassett, RG, Robertson, IK, Ball, MJ, Geraghty, DP and Coombes, JS (2011). Atorvastatin Slows the Progression of Ckd in Patients with Inflammation. ANZSN 2011: 47th Annual Scientific Meeting Australian and New Zealand Society of Nephrology, Adelaide, SA, Australia, 19-21 September 2011. MALDEN: WILEY-BLACKWELL. doi: 10.1111/j.1440-1797.2011.01490.x

Atorvastatin Slows the Progression of Ckd in Patients with Inflammation

2010

Journal Article

Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial

Fassett, Robert G., Robertson, Iain K., Ball, Madeleine J., Geraghty, Dominic P. and Coombes, Jeff S. (2010). Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. Atherosclerosis, 213 (1), 218-224. doi: 10.1016/j.atherosclerosis.2010.07.053

Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial

2010

Journal Article

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

Baigent, C., Landray, M., Reith, C., Dasgupta, T., Emberson, J., Herrington, W., Lewis, D., Mafham, M., Collins, R., Bray, C., Chen, Y., Baxter, A., Young, A., Hill, M., Knott, C., Cass, A., Feldt-Rasmussen, B., Fellström, B., Grobbee, R., Grönhagen-Riska, C., Haas, M., Holdaas, H., Hooi, L. S., Jiang, L., Kasiske, B., Krairittichai, U., Levin, A., Massy, Z., Tesar, V. ... Schenck, J. (2010). Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. American Heart Journal, 160 (5), 785-794.e10. doi: 10.1016/j.ahj.2010.08.012

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

2010

Journal Article

Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial

Fassett, Robert G., Robertson, Iain K., Ball, Madeleine J., Geraghty, Dominic P. and Coombes, Jeff S. (2010). Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial. Atherosclerosis, 213 (1), 218-224. doi: 10.1016/j.atherosclerosis.2010.07.053

Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial

2010

Journal Article

Omega-3 polyunsaturated fatty acids in the treatment of kidney disease

Fassett, Robert G., Gobe, Glenda C., Peake, Jonathan M. and Coombes, Jeff S. (2010). Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. American Journal of Kidney Diseases, 56 (4), 728-742. doi: 10.1053/j.ajkd.2010.03.009

Omega-3 polyunsaturated fatty acids in the treatment of kidney disease

2010

Journal Article

A randomized, controlled trial of early versus late initiation of dialysis

Cooper, Bruce A., Branley, Pauline, Bulfone, Liliana, Collins, John F., Craig, Jonathan C., Fraenkel, Margaret B., Harris, Anthony, Johnson, David W., Kesselhut, Joan, Li, Jing Jing, Luxton, Grant, Pilmore, Andrew, Tiller, David J., Harris, David C., Pollock, Carol A., IDEAL Study Group, Fassett, R. and Healy, H. (2010). A randomized, controlled trial of early versus late initiation of dialysis. New England Journal of Medicine, 363 (7), 609-619. doi: 10.1056/NEJMoa1000552

A randomized, controlled trial of early versus late initiation of dialysis

2010

Journal Article

Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimize complications (Timely PD Study)

Ranganathan, Dwarakanathan, Baer, Richard, Fassett, Robert G., Williams, Nicola, Han, Thin, Watson, Melanie and Healy, Helen (2010). Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimize complications (Timely PD Study). BMC Nephrology, 11 (1 Article number 11) 11, 1-5. doi: 10.1186/1471-2369-11-11

Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimize complications (Timely PD Study)

2010

Journal Article

Intravenous versus oral rehydration in athletes

van Rosendal, Simon Piet, Osborne, Mark Andrew, Fassett, Robert Gordon, Lancashire, Bill and Coombes, Jeff Scott (2010). Intravenous versus oral rehydration in athletes. Sports Medicine, 40 (4), 327-346. doi: 10.2165/11319810-000000000-00000

Intravenous versus oral rehydration in athletes

2010

Journal Article

Retinal basement membrane abnormalities and the retinopathy of Alport syndrome

Savige, Judy, Liu, John, Cabrera DeBuc, Delia, Handa, James T., Hageman, Gregory S., Wang, Yan Yan, Parkin, John D., Vote, Brendan, Fassett, Rob, Sarks, Shirley and Colville, Deb (2010). Retinal basement membrane abnormalities and the retinopathy of Alport syndrome. Investigative Ophthalmology & Visual Science, 51 (3), 1621-1627. doi: 10.1167/iovs.08-3323

Retinal basement membrane abnormalities and the retinopathy of Alport syndrome

Funding

Current funding

  • 2021 - 2025
    Feasibility, acceptability and effectiveness of the Physical Activity Intelligence (PAI) e-health program for cardiac patients from the Defence community
    Defence Health Foundation Grants for Medical Research
    Open grant

Past funding

  • 2019 - 2020
    Feasibility, acceptability and efficacy of the Physical Activity Index (PAI) e-health Program in Type 2 Diabetes
    Diabetes Australia Research Program
    Open grant
  • 2014 - 2020
    Chronic Kidney Disease Centre of Research Excellence
    NHMRC Centres of Research Excellence
    Open grant
  • 2014
    Cellular metabolic respirometry and enzymatic assessment suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014 - 2016
    Effects of high intensity interval training on exercise capacity, mitochondrial function and muscle atrophy in patients with chronic kidney disease
    Kidney Health Australia
    Open grant
  • 2013 - 2015
    Biomarkers of Chronic Kidney Disease and its Progression in Northern Tasmanians
    University of Tasmania
    Open grant
  • 2012 - 2013
    Educational Grant
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2012
    Clinical and Nutritional Biomarker Platform
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011
    A metabolic testing suite for clinical exercise physiology, sports science and sports nutrition research
    NHMRC Equipment Grant
    Open grant
  • 2011 - 2015
    A randomised, placebo-controlled trial of Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia in chronic kidney disease
    NHMRC Project Grant
    Open grant
  • 2011 - 2014
    Chronic Kidney Disease in Queensland (CKD.QLD)
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2010
    An ultrasound imaging suite for investigating musculoskeletal and cardiovascular function in health and disease
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Partnership Opportunity with CKD.QLD
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2009 - 2011
    Effects of Acute Renal Failure
    Mayne Bequest Fund
    Open grant
  • 2008
    Mass spectrometer for HMS laboratory
    UQ Major Equipment and Infrastructure
    Open grant

Supervision

Availability

Professor Robert Fassett is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Completed supervision

Media

Enquiries

For media enquiries about Professor Robert Fassett's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au